Gül Sema Yıldıran

6PUBLICATIONS
95CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 27, 2026
First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

|Mar 28, 2026
Clinical Significance of Achieving No Evidence of Disease in HER2-Positive Metastatic Breast Cancer: A Multicenter Study by Turkish Oncology Group (TOG).

Bengü Dursun, Şendağ Yaslıkaya, Serhat Sekmek

|Mar 23, 2026
Real-world effectiveness of total neoadjuvant therapy in locally advanced rectal cancer: a multicenter retrospective study.

Osman Sütcüoğlu, Orhun Akdoğan, İlknur Deliktaş Onur

|Sep 27, 2025
A Real-World Evaluation of Clinical Prognostic Scores in Advanced Melanoma Treated with Immune Checkpoint Inhibitors.

Gul Sema Yildiran Keskin, Nuri Karadurmus

|Jun 27, 2025
Survival Outcomes in Metastatic Germ Cell Tumors: A Multicenter Study from Turkey.

Gul Sema Yildiran Keskin, Ozge Yetginoglu, Sertac Vurgun

|Feb 16, 2019
Relationship between plasma YKL-40 levels and endothelial dysfunction in chronic kidney disease

Gül Sema Keskin, Özant Helvacı, Çağrı Yayla

Pageof 1

Frequent Collaborators

3 joint publications

Musa Barış Aykan

2 joint publications

Elif Şahin

2 joint publications

Huseyin Salih Semiz

2 joint publications

Abdullah Sakin